Table 1.
Characteristics of study cohorts for longitudinal analyses after vaccination with three doses of Comirnaty
| Cohort 1 (CoVaAdapt) |
Cohort 2 | |
|---|---|---|
| Vaccines | BNT162b2 mRNA (3x) | BNT162b2 mRNA (3x) |
| Number of volunteers | n = 29 | N = 38 |
| Age in years, median (IQR) [range] | 44 (31–52) [24-59] | 39.5 (28–53) [25-62] |
| Sex, n (%) Female | 16 (55%) | 27 (71%) |
| Sex, n (%) Male | 13 (45%) | 11 (29%) |
| Time intervals between immunizations in days, median (IQR) [range] first to second: second to third: |
23 (23–25) [22-28] 227 (216.5–229) [196–244] |
23 (22–28) [14-28] 207 (195–216) [170–251] |
| Time interval from immunization to blood collection in days, median (IQR) [range] post first: post second: Follow-up post second: post third: Follow-up post third: |
10 (9–10.5) [8-13] 10 (10–11) [9-11] 210 (209–210) [195–235] 10 (10–10) [9-12] 189 (189–190) [157–202] |
14 (14–14) [7-18] 14 (14–17) [13-28] 165 (154–172) [147–194] 17 (14–23) [13-61]] n.a. |